
Amit Agarwal
@agarwalonc
Hem/Onc doc, Passionate about bringing novel drugs to oncology patients... doing it now as a biotech executive... views my own.
ID: 20520873
10-02-2009 15:47:19
1,1K Tweet
925 Followers
833 Following






The first dosing of a patient in the U.S. with a base-edited therapeutic has taken place. Congratulations to the Beam Therapeutics team on achieving this milestone. 🍻


I remember this one like yesterday... this is one of my favorite Sachin Tendulkar ODI innings... and there are many!!! thecricketmonthly.com/story/1374631/…





In patients w/ cardiovascular disease & overweight or obesity but no diabetes, semaglutide was superior to placebo in lowering the risk of major adverse cardiovascular events at a mean follow-up of 39.8 mos. Full SELECT trial results: nej.md/465pj91 #AHA23 AHA Science


New #JITC review: Therapeutic avenues for γδ T cells in cancer bit.ly/3sSCaOc Bruno Silva-Santos



